Effects of different dose tranexamic acid in fibrinolysis during liver transplantation
10.3969/j.issn.1006-5725.2015.17.036
- VernacularTitle:不同剂量氨甲环酸对肝移植术中纤溶功能的影响
- Author:
Zhen CHEN
;
Kunhe LI
;
Junying GUO
;
Liangcan XIAO
;
Xue BAI
- Publication Type:Journal Article
- Keywords:
Liver transplantation;
Tranexamic acid;
Fibrinolysis;
D-dimers;
Fibrin degradation product
- From:
The Journal of Practical Medicine
2015;(17):2877-2880
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of different dose of tranexamic acid in fibrinolysis during liver transplantation. Methods Sixty ASA Ⅱ~ Ⅳ liver transplant recipients, were randomly, double-blind assigned to one of 3 groups (n = 20): group control (group C), group tranexamic acid 1 (group T1) and group tranexamic acid 2 (group T2). The patients in group C received a loading dose of normal saline 10 mL, then continued infuse normal saline at 20 mL/h until neohepatic phase 120 min, while in other two groups, patients received a loading dose of tranexamic acid 1 g, totally 10 mL, followed by continuous infusion at 10 mg/(kg·h) in group T1 or 20 mg/(kg·h) in group T2 until neohepatic phase 120 min. Prothrombin time, fibrinogen, fibrin degradation product and D-dimers were measured before operation (T0), 120 min after the skin incision (T1), nonhepatic phase 30 min (T2), neohepatic phase 120 min (T3). Blood loss, fresh frozen plasma dosage, fibrinogen dosage and thromboembolic events were recorded. Results The plasma concentration of fibrin degradation product and plasma concentration of D-dimers were different in the 3 groups, group T2< group T1 0.05). Conclusions Continuous infusion of tranexamic acid can inhibit fibrinolysis during liver transplantation. No adverse event of thrombosis was detected. Larger dose of tranexamic acid can reduce blood loss and fresh frozen plasma transfusion.
